Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Vaccines
Vaccines
Page 24 of 31
Politics
Biden’s national coronavirus strategy is starting to take shape—and it’s very different than Trump’s
By
The Associated Press
and
Lisa Mascaro
November 28, 2020
Finance
Bet on these stocks for the millennial-powered COVID recovery, says Goldman’s Katie Koch
By
Anne Sraders
November 28, 2020
Health
AstraZeneca eyes another global trial for its COVID vaccine following dosage blip
By
Suzi Ring
,
James Paton
and
Bloomberg
November 27, 2020
Health
For AstraZeneca’s COVID vaccine, less may be more—and that’s puzzling researchers
By
Angelica LaVito
,
John Lauerman
and
Bloomberg
November 25, 2020
Health
AstraZeneca says its Covid-19 vaccine is up to 90% effective
By
Jeremy Kahn
November 23, 2020
Newsletters
The vaccine jolt fades, sinking global stocks—except for this one surprising sector
By
Bernhard Warner
November 12, 2020
Health
U.K. to use A.I. to spot dangerous side effects in the millions of COVID-19 vaccinations it will deliver
By
Jeremy Kahn
November 5, 2020
Health
AstraZeneca-Oxford COVID vaccine on track for year end, CEO Pascal Soriot says
By
Suzi Ring
,
James Paton
and
Bloomberg
November 5, 2020
Health
The science behind the leading COVID vaccine candidates
By
Sy Mukherjee
November 4, 2020
Conferences
CEO of Chinese drugmaker defends his COVID vaccine’s January 2022 timeline
By
Naomi Xu Elegant
October 27, 2020
International
What will it take for Beijing to meet its climate goals? Changing how it governs entirely
By
Grady McGregor
October 22, 2020
Health
U.K. drug trial will deliberately expose young people to coronavirus, despite ethical concerns
By
Jeremy Kahn
October 21, 2020
Health
J&J CEO still optimistic COVID-19 vaccine could come as early as this year
By
Robert Hackett
October 14, 2020
Health
A Pelosi snub and a giant federal COVID grant: Another dizzying day in Washington for the U.K.’s AstraZeneca
By
Jeremy Kahn
October 12, 2020
International
Joining WHO’s COVID vaccine program is a chance for China to exploit the U.S.’s absence
By
Eamon Barrett
October 9, 2020
Most Popular
Law
DOGE cancelled a $349,000 grant to replace a museum’s HVAC after ChatGPT flagged it as DEI, court documents show
By
Sasha Rogelberg
Economy
Social Security has 6 years left. The fix that sounds cruelest may be the smartest
By
Nick Lichtenberg
Economy
Gen Z’s straight‑A boom is quietly shrinking their paychecks
By
Jake Angelo